Feature | April 06, 2012

St. Jude Medical Discontinues Two CRT Leads, Identifies Issue With External Conductors

April 6, 2012 — St. Jude Medical announced it is proactively informing physicians about visual observations of externalized conductors on the silicone end of QuickSite and QuickFlex left ventricular (LV) leads, used to connect cardiac resynchronization therapy (CRT) devices to the heart.

There have been no reports of patient injury or loss of therapy due to externalized conductors in these leads, but as a conservative measure, St. Jude Medical is communicating with physicians about the incidence rate so they have the most updated lead performance information with which to make important patient care decisions. The company will no longer sell the lead models and notes that the overall safety and reliability of QuickSite and QuickFlex leads continues to be comparable to currently available CRT leads from other manufacturers.

A copy of the physician letter and additional information about the leads can be found at sjmprofessional.com.

St. Jude Medical has confirmed 39 cases of externalized conductors, out of 171,000 QuickSite and QuickFlex leads sold worldwide, resulting in a current reported incidence rate of 0.023 percent, or 2.3 in 10,000. Because these leads continue to function normally, the company expects that this rate is under-reported. Based on an analysis of leads returned to the company and recent fluoroscopic images of implanted leads still in clinical use, St. Jude Medical estimates that 3 to 4 percent of QuickSite and QuickFlex leads may exhibit externalized conductors. As a result of this estimated rate, the company felt it was prudent to communicate with physicians about the externalized conductors at this time.

This medical device advisory does not affect the company’s continued sale of its newer QuickFlex µ (micro) or Quartet LV leads, which are fully insulated using Optim insulation along the entire length of the lead body. Optim insulation is a hybrid material that combines the biostability and flexibility of high-performance silicone rubber with the strength, tear resistance and abrasion resistance of polyurethane to provide increased durability and flexibility. There have been no reports or observations of externalized conductors in these newer Optim-insulated leads, out of more than 65,000 leads sold worldwide since 2008.

An externalized conductor occurs when the cable, or conductor, from inside the lead wears through the outer silicone insulation around the lead and appears outside the insulation body. This can be visualized on an X-ray or fluoroscopic image; however, these cables are protected by an additional layer of insulation, and therefore can continue to function properly if an externalization occurs.

For more information: www.sjm.com

Related Content

News | Heart Failure| August 28, 2015
August 28, 2015 — BioControl Medical said it has completed enrollment in its INOVATE-HF (INcrease Of VAgal TonE in He
BioSig Technologies, research agreement, UCLA, Pure EP System, EP lab, ventricular tachycardia model, VT
Technology | EP Lab| August 20, 2015
BioSig Technologies announced it has signed a sponsored research agreement with the regents of the University of...
Biotronik, BioCONTINUE study, CRT-D, defibrillator, cardiac resynchronization therapy device, heart failure, first replacement
News | Cardiac Resynchronization Therapy Devices (CRT)| August 17, 2015
Biotronik announced that the first patient has been enrolled in the BioCONTINUE clinical trial (BIOtronik study to...
CMS, additional participants, Bundled Payments for Care Improvement initiative, Medicare, eipsodes of care
News | Business| August 17, 2015
The Centers for Medicare & Medicaid Service (CMS) announced that over 2,100 healthcare facilities have agreed to...
Biotronik, BIOGUARD-MI Study, BioMonitor, cardiac arrhythmias, early detection, remote monitoring
News | Implantable Cardiac Monitor (ICM)| August 11, 2015
Biotronik announced the first enrollments in the BIO|GUARD-MI1 study. The study will investigate whether the early...
Boston Scientific, Preventice Solutions, equity investment, sales cooperation agreement, cardiac monitoring

BodyGuardian product family. Image courtesy of Preventice Solutions.

News | Remote Monitoring| August 11, 2015
Boston Scientific has become a significant shareholder and will become the exclusive worldwide sales and marketing...
Passive Elastography, TTP, U.K., ablation, atrial fibrillation
News | Cardiovascular Ultrasound| August 10, 2015
The Technology Partnership (TTP), a U.K.-based research and product development company, has made major advances in the...
Biotronik, CE approval, 3T MRI scanning, pacemakers, ICDs
News | Implantable Cardioverter Defibrillators (ICD)| August 03, 2015
Biotronik announced CE approval of 3 Tesla (T) magnetic resonance imaging (MRI) scanning with exclusion zone for its...
Overlay Init